Ariad Pharmaceuticals Inc fka ARIA

[micanwait]

2da -- My opinion. Denner is second tier. He gave us hope for a while but has not been able to close.

The fund business is very competitive. Watch for Sarissa to lose investors in the next year. It is a "show me the money" business.

Sad. Ariad had good science people and a great lab. All wasted at a time when lesser companies have been gobbled up. Watch for a fire sale and a price under $10.

As you can tell, I've lost confidence in management. Good luck with your lawsuit... not sure how you will be able to afford it.
On the plus side, you may only have to face the Ariad in-house counsel whose record speaks for itself.